- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07774845
Platelets and Plasma Lipids Relationship as a Biomarker and Potential Therapeutic Target of Thrombogenesis
Development and Validation of a New Method to Valuate the Platelet-Plasma Lipid Relationship as a Biomarker and Potential Therapeutic Target of Thrombogenesis
The objective of this clinical trial is to compare the effect of two different lipid emulsion formulations versus no emulsion on platelet aggregation in individuals without a history of ischemic disease. The hypothesis of this study is:
Platelet aggregation is inversely associated with higher plasma lipid concentrations.
The researchers will compare platelet aggregation in the presence and absence of lipid nanoemulsions in vitro through three pathways using the agonists collagen, adenosine diphosphate, and arachidonic acid. The tests will be performed using light-transmission aggregometry. Various participant parameters, such as lipid profile, will be evaluated to analyze possible correlations with the observed results.
Participants must:
Meet the study's inclusion criteria; Sign the informed consent form; Report to the blood draw laboratory at InCor's AB on the scheduled date and time after fasting for at least 8 hours.
Studieoversikt
Status
Forhold
Detaljert beskrivelse
A prospective case-control study in which the selected volunteers will serve as their own controls.
Participant Selection:
Volunteers with no known atherosclerotic disease will be selected from among employees of InCor/HCFMUSP and, if necessary, from the donor waiting list of the HCFMUSP blood bank.
Studietype
Registrering (Antatt)
Kontakter og plasseringer
Studiekontakt
- Navn: José C Nicolau, Senior Professor
- Telefonnummer: 11971514117
- E-post: jose.nicolau@fm.hc.usp.br
Studer Kontakt Backup
- Navn: Juliana L L F Regueira, Postdoctoral Res. Associate
- Telefonnummer: 11959564983
- E-post: julianaliraregueira@gmail.com
Studiesteder
-
-
São Paulo
-
São Paulo, São Paulo, Brasil, 05403-900
- Rekruttering
- Heart Institute, University of São Paulo Medical School (InCor/HCFMUSP)
-
Underetterforsker:
- Juliana L. L. F. Regueira, PhD
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Voksen
- Eldre voksen
Tar imot friske frivillige
Prøvetakingsmetode
Studiepopulasjon
Beskrivelse
Inclusion Criteria:
- Men and women aged ≥ 40 years.
- Willingness to sign the informed consent form.
- Absence of known atherosclerotic disease
Exclusion Criteria:
- Use of antiplatelet agents.
- Use of anticoagulants.
- Use of lipid-lowering agents.
- Use of oral hypoglycemic agents or insulin.
- Known atherosclerotic disease.
- Refusal to sign the informed consent form
Studieplan
Hvordan er studiet utformet?
Designdetaljer
Kohorter og intervensjoner
Gruppe / Kohort |
|---|
|
Control group
The same group of study participants.
Platelet aggregation tests without the addition of lipid nanoemulsions.
|
|
Case group
Study participants.
Platelet aggregation tests with the addition of lipid nanoemulsions.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Effect of Lipid Emulsions on Platelet Aggregation Assessed by Optical Aggregometry
Tidsramme: Day 1 (single blood sample collection)
|
Comparison of the effect of different lipid emulsion formulations versus no emulsion (control) on platelet aggregation in blood samples from individuals without a history of ischemic disease.
|
Day 1 (single blood sample collection)
|
Samarbeidspartnere og etterforskere
Sponsor
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Andre studie-ID-numre
- SDC: 6137/25/148
- 2023/10447-4 (Annet stipend/finansieringsnummer: Fapesp)
- 2025/29035-3 (Annet stipend/finansieringsnummer: Fapesp)
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
IPD-planbeskrivelse
IPD-deling Støtteinformasjonstype
- SEVJE
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .